Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.38 USD | +1.40% |
|
+1.40% | +76.54% |
Business Summary
Number of employees: 464
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cancer Medicines
100.0
%
| 278 | 100.0 % | 238 | 100.0 % | -14.37% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
88.8
%
| 0 | 0.0 % | 211 | 88.8 % | - |
Europe (excluding Germany)
11.2
%
| - | - | 27 | 11.2 % | - |
Asia
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Tim Demuth
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-09-30 |
Julia Neugebauer
IRC | Investor Relations Contact | - | 06-08-31 |
Daniel Palmacci
PRN | Corporate Officer/Principal | - | 20-06-30 |
Ann Merchant
PRN | Corporate Officer/Principal | 59 | 17-12-31 |
Ralf Ostendorp
PRN | Corporate Officer/Principal | - | 98-12-31 |
Corporate Officer/Principal | - | 94-04-30 | |
Klaus de Wall
AUD | Comptroller/Controller/Auditor | - | 05-05-31 |
Corporate Officer/Principal | - | 97-12-31 | |
Human Resources Officer | 54 | 12-05-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Curran
BRD | Director/Board Member | 56 | 19-05-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,716,423 | 2,130,820 ( 5.650 %) | 53,685 ( 0.1423 %) | 5.650 % |
Company contact information
![address MorphoSys AG(MPSYF)](https://cdn.zonebourse.com/static/address/120790838.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.13% | 46.93B | |
+37.01% | 39.08B | |
-8.73% | 38.48B | |
+28.09% | 31.01B | |
-12.26% | 26.14B | |
+10.57% | 25.88B | |
+45.05% | 14.15B | |
+32.23% | 12.53B | |
-6.56% | 11.36B |
- Stock Market
- Equities
- MOR Stock
- MPSYF Stock
- Company MorphoSys AG